FDA Warning Letter — Fagron, Inc

Case 624255 — FEI 1000174332

The FDA took a Warning Letter action against Fagron, Inc on June 14, 2022 (Saint Paul, MN). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.

Action Details

Facility
Fagron, Inc
Date
June 14, 2022
Fiscal Year
2022
Product Type
Drugs
Center
CDER
Location
Saint Paul, MN (United States)